Comments
Chennai-based Orchid Pharma Ltd has informed the BSE that the company has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai, near Chennai. The facility was inspected by USFDA in May 2015.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.